Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review
暂无分享,去创建一个
[1] J. L. López Gutiérrez,et al. Therapeutic strategies and clinical evolution of patients with infantile fibrosarcoma: a unique paediatric case series , 2023, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[2] Yue He,et al. Atypical/unbalanced ETV6/NTRK3 rearrangement in salivary secretory carcinoma with a focus on the incidence, the patterns, and the clinical implications. , 2022, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[3] M. Mandal,et al. Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma. , 2022, Cancer letters.
[4] K. Pajtler,et al. Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring an NTRK Oncogenic Fusion , 2022, JCO precision oncology.
[5] T. Sullivan,et al. Long term follow-up of congenital infantile fibrosarcoma of the orbital region. , 2022, Orbit.
[6] J. López-Gutiérrez,et al. Larotrectinib as an Effective Therapy in Congenital Infantile Fibrosarcoma: Report of Two Cases , 2022, European journal of pediatric surgery reports.
[7] M. Kotb,et al. Jejunal infantile fibrosarcoma: An unusual cause of neonatal intestinal obstruction , 2021, Congenital anomalies.
[8] J. L. López Gutiérrez,et al. Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report , 2021, Pediatric hematology and oncology.
[9] C. Antonescu,et al. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] R. Has,et al. The Giant Infantile Fibrosarcoma of Fetal Oropharynx and Anterior Neck , 2020, Fetal and pediatric pathology.
[11] A. Pappo,et al. A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib , 2020, Pediatric blood & cancer.
[12] S. DuBois,et al. The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers , 2020, Pediatric Drugs.
[13] S. Bielack,et al. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] N. Shukla,et al. Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients. , 2019, Journal of Clinical Oncology.
[15] Jessica L. Davis,et al. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. , 2018, The Lancet. Oncology.
[16] M. Harris,et al. Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy , 2018, Modern Pathology.
[17] Funda Meric-Bernstam,et al. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children , 2018, The New England journal of medicine.
[18] R. Craigie,et al. Congenital infantile fibrosarcoma of the colon: a case series and literature review , 2014, Pediatric Surgery International.
[19] M. Nikiforova,et al. ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancer , 2014, Cancer.
[20] I. Brucknerová,et al. Unusual cause of neonatal intestinal obstruction , 2012 .
[21] E. Connolly,et al. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. , 2012, Breast.
[22] G. Webersinke,et al. Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia , 2011, Diagnostic pathology.
[23] A. Ferrari,et al. Infantile fibrosarcoma: management based on the European experience. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] F. Enzinger,et al. Infantile fibrosarcoma , 1976, Cancer.
[25] Jia-xin Yang,et al. Ovarian yolk sac tumor in postmenopausal females , 2018, Medicine.
[26] R. Doebele,et al. TRKing down an old oncogene in a new era of targeted therapy. , 2015, Cancer discovery.
[27] A. Waweru,et al. Chemotherapy induced myelosuppression. , 2007, East African medical journal.
[28] D. C. Henckel,et al. Case report. , 1995, Journal.
[29] S. Siegel,et al. Problems in the chemotherapy of cancer in the neonate. , 1981, The American journal of pediatric hematology/oncology.
[30] John H. Jopson,et al. A REPORT OF TWO CASES , 1902 .